KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $443,000 | -68.8% | 34,800 | -62.3% | 0.34% | -74.8% |
| Q2 2014 | $1,421,000 | -16.6% | 92,400 | -7.6% | 1.35% | -8.1% |
| Q1 2014 | $1,704,000 | +198.9% | 100,000 | +127.3% | 1.46% | +149.6% |
| Q4 2013 | $570,000 | -23.8% | 44,000 | -40.6% | 0.59% | -28.2% |
| Q3 2013 | $748,000 | +30.1% | 74,100 | -3.8% | 0.82% | -3.0% |
| Q2 2013 | $575,000 | – | 77,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |